GlycoMimetics (GLYC) Short Interest Ratio & Short Volume → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free GLYC Stock Alerts $1.62 -0.18 (-10.00%) (As of 05/1/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability GlycoMimetics Short Interest DataCurrent Short Volume3,010,000 sharesPrevious Short Volume1,590,000 sharesChange Vs. Previous Month+89.31%Dollar Volume Sold Short$6.79 millionShort Interest Ratio / Days to Cover6.6Last Record DateApril 15, 2024Outstanding Shares64,450,000 sharesPercentage of Shares Shorted4.67%Today's Trading Volume980,598 sharesAverage Trading Volume829,818 sharesToday's Volume Vs. Average118% Short Selling GlycoMimetics ? Sign up to receive the latest short interest report for GlycoMimetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGLYC Short Interest Over TimeGLYC Days to Cover Over TimeGLYC Percentage of Float Shorted Over Time Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. GlycoMimetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,010,000 shares $6.79 million +89.3%N/A6.6 $2.26 3/31/20241,590,000 shares $4.77 million +6.7%N/A4.3 $3.00 3/15/20241,490,000 shares $3.81 million -4.5%N/A4.2 $2.56 2/29/20241,560,000 shares $4.51 million +9.1%N/A4.6 $2.89 2/15/20241,430,000 shares $4.42 million +43.3%N/A4.5 $3.09 1/31/2024997,900 shares $2.99 million +24.8%N/A3.5 $3.00 Get the Latest News and Ratings for GLYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024799,700 shares $2.49 million +40.3%N/A3.3 $3.11 12/31/2023570,000 shares $1.35 million -11.2%N/A2.9 $2.36 12/15/2023641,600 shares $1.27 million -23.7%N/A3.8 $1.98 11/30/2023841,200 shares $1.38 million -4.3%N/A7 $1.64 11/15/2023878,900 shares $1.22 million -1.6%N/A7.5 $1.39 10/31/2023893,500 shares $1.12 million -8.9%N/A7.3 $1.25 10/15/2023981,100 shares $1.39 million +4.3%N/A8.1 $1.42 9/30/2023940,300 shares $1.41 million -7.8%N/A8.2 $1.50 9/15/20231,020,000 shares $1.44 million -1.9%N/A8.8 $1.41 8/31/20231,040,000 shares $1.66 million -6.3%N/A7.6 $1.60 8/15/20231,110,000 shares $1.78 million -4.3%N/A6.6 $1.60 7/31/20231,160,000 shares $1.90 million -4.9%N/A5.1 $1.64 7/15/20231,220,000 shares $2.01 million -1.6%N/A5.2 $1.65 6/30/20231,240,000 shares $2.16 million +1.6%N/A5.1 $1.74 6/15/20231,220,000 shares $2.33 million -14.1%N/A4.3 $1.91 5/31/20231,420,000 shares $2.64 million +7.6%N/A4.5 $1.86 5/15/20231,320,000 shares $2.75 million -2.2%N/A2.8 $2.08 4/30/20231,350,000 shares $1.89 million -13.5%N/A1.3 $1.40 4/15/20231,560,000 shares $2.29 million -23.5%N/A1.2 $1.47 3/31/20232,040,000 shares $2.57 million -0.5%N/A1.5 $1.26 3/15/20232,050,000 shares $3.05 million -23.5%4.5%1.4 $1.49 2/28/20232,680,000 shares $4.13 million +92.8%5.8%1.8 $1.54 2/15/20231,390,000 shares $2.11 million +40.0%3.0%1 $1.52 1/31/2023992,600 shares $2.89 million +50.2%2.2%1 $2.91 1/15/2023660,700 shares $2.00 million +7.8%1.6%1 $3.02 12/30/2022613,000 shares $1.86 million +20.8%1.5%1.1 $3.03 12/15/2022507,300 shares $1.03 million -0.6%1.2%1.2 $2.04 11/30/2022510,200 shares $1.10 million -14.2%1.2%1.4 $2.16 11/15/2022594,500 shares $1.01 million +3.6%1.4%1.9 $1.70 10/31/2022574,100 shares $389,412.03 +19.7%1.4%5.1 $0.68 10/15/2022479,700 shares $298,133.55 +2.4%1.1%3.9 $0.62 9/30/2022468,700 shares $258,581.79 -5.8%1.1%3.6 $0.55 9/15/2022497,300 shares $341,098.07 -1.8%1.2%3.7 $0.69 8/31/2022506,300 shares $384,788.00 +6.1%1.2%3.5 $0.76Biden to Launch “FedNOW” [Move Your Money Now] (Ad)Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. GLYC Short Interest - Frequently Asked Questions What is GlycoMimetics' current short interest? Short interest is the volume of GlycoMimetics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 3,010,000 shares of GLYC short. Learn More on GlycoMimetics' current short interest. What is a good short interest ratio for GlycoMimetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GLYC shares currently have a short interest ratio of 7.0. Learn More on GlycoMimetics's short interest ratio. Which institutional investors are shorting GlycoMimetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GlycoMimetics: Simplex Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is GlycoMimetics' short interest increasing or decreasing? GlycoMimetics saw a increase in short interest in April. As of April 15th, there was short interest totaling 3,010,000 shares, an increase of 89.3% from the previous total of 1,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does GlycoMimetics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to GlycoMimetics: Societal CDMO, Inc. (0.00%), Repare Therapeutics Inc. (2.13%), Immunic, Inc. (3.20%), Citius Pharmaceuticals, Inc. (8.29%), Abeona Therapeutics Inc (7.95%), Cartesian Therapeutics, Inc. (45.28%), Karyopharm Therapeutics Inc. (20.23%), CytomX Therapeutics, Inc. (5.30%), Relmada Therapeutics, Inc. (5.67%), Adicet Bio, Inc. (9.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short GlycoMimetics stock? Short selling GLYC is an investing strategy that aims to generate trading profit from GlycoMimetics as its price is falling. GLYC shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GlycoMimetics? A short squeeze for GlycoMimetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLYC, which in turn drives the price of the stock up even further. How often is GlycoMimetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLYC, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Societal CDMO Short Interest Repare Therapeutics Short Interest Immunic Short Interest Citius Pharmaceuticals Short Interest Abeona Therapeutics Short Interest Cartesian Therapeutics Short Interest Karyopharm Therapeutics Short Interest CytomX Therapeutics Short Interest Relmada Therapeutics Short Interest Adicet Bio Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLYC) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press